0000000000373180

AUTHOR

John Lally

0000-0003-3038-0625

showing 9 related works from this author

Hospitalisation and length of hospital stay following first-episode psychosis:Systematic review and meta-analysis of longitudinal studies

2019

AbstractBackgroundReducing hospitalisation and length of stay (LOS) in hospital following first episode psychosis (FEP) is important, yet reliable measures of these outcomes and their moderators are lacking. We conducted a systematic review and meta-analysis to investigate the proportion of FEP cases who were hospitalised after their first contact with services and the LOS in a hospital during follow-up.MethodsStudies were identified from a systematic search across major electronic databases from inception to October 2017. Random effects meta-analyses and meta-regression analyses were conducted.Results81 longitudinal studies encompassing data for 23 280 FEP patients with an average follow-u…

First contactAdultMalePediatricsmedicine.medical_specialtyFirst episode psychosisAsiaTime FactorsAdolescentUntreated psychosisinpatient03 medical and health sciencesYoung Adult0302 clinical medicinelength of stayFirst episode psychosismedicinefollow-upHumansLongitudinal StudiesApplied Psychologybusiness.industryhospitalisationAustraliaLength of Staymedicine.disease030227 psychiatryEuropeHospitalizationschizophreniaPsychiatry and Mental healthPsychotic DisordersSchizophreniaMeta-analysisNorth AmericaSchizophreniaoutcomeFemalebusinessHospital stay030217 neurology & neurosurgerySystematic searchNew Zealand
researchProduct

The Representativeness of Participants With Severe Mental Illness in a Psychosocial Clinical Trial

2018

Introduction: Cardiovascular morbidity and mortality are increased in severe mental illnesses (SMI). Trials of psychosocial health interventions to improve physical health in SMI, including in treatment-resistant schizophrenia, have shown some benefit. However, the representativeness of participants in such trials has not been determined. Method: We utilized an anonymised case register to determine if participants in a randomized controlled trial (RCT) of a novel psychosocial health intervention aiming to improve physical health in SMI had similar severity of illness to eligible non-participants. A retrospective database analysis was performed, using Health of the Nation Outcome Scale (HoNO…

medicine.medical_specialtylcsh:RC435-571PopulationPsychological interventionoutcomesHealth interventionlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawlcsh:PsychiatrySeverity of illnessMedicinepsychosiseducationOriginal Researchhealth promotion interventionPsychiatryeducation.field_of_studybusiness.industrycardiovascularMental health030227 psychiatryClinical trialschizophreniaPsychiatry and Mental healthPhysical therapybusinessPsychosocial030217 neurology & neurosurgeryFrontiers in Psychiatry
researchProduct

Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 5…

2021

Introduction: Despite respiratory disease being a major cause of excess mortality in people with schizophrenia, the prevalence of respiratory conditions in this population is poorly defined. A systematic review and meta-analysis were conducted to establish the prevalence and association of respiratory diseases in people with schizophrenia. Material and methods: Major electronic databases were searched from inception to 27 April 2020 for articles reporting respiratory disease (asthma, chronic obstructive pulmonary disease [COPD], pneumonia, and tuberculosis) in people with schizophrenia and, where possible, a control group. A random-effects meta-analysis was conducted. The study was register…

medicine.medical_specialtyPopulationPulmonary Disease Chronic ObstructiveInternal medicinePrevalenceHumansMedicineeducationBiological PsychiatryAsthmaCOPDeducation.field_of_studybusiness.industryRespiratory diseasePneumoniaOdds ratiomedicine.diseaserespiratory diseaseAsthmaPsychiatry and Mental healthPneumoniaSchizophreniaLung diseaseMeta-analysisSchizophreniabusinessSchizophrenia Research
researchProduct

A health promotion intervention to improve lifestyle choices and health outcomes in people with psychosis: a research programme including the IMPaCT …

2020

Background People with psychotic disorders have reduced life expectancy largely because of physical health problems, especially cardiovascular disease, that are complicated by the use of tobacco and cannabis. Objectives We set out to (1) chart lifestyle and substance use choices and the emergence of cardiometabolic risk from the earliest presentation with psychosis, (2) develop a pragmatic health promotion intervention integrated within the clinical teams to improve the lifestyle choices and health outcomes of people with psychosis and (3) evaluate the clinical effectiveness and cost-effectiveness of that health promotion intervention. Design We performed a longitudinal cohort study of peo…

dysglycaemiamedicine.medical_specialtyhealth promotionMotivational interviewingmotivational interviewinglaw.invention03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Randomized controlled triallawIntervention (counseling)medicinepsychosis030212 general & internal medicinerctFirst episodelifestyle choicesbusiness.industrylcsh:Public aspects of medicineweightlcsh:RA1-1270waist circumferenceMental health030227 psychiatryHealth promotionquality of lifeFamily medicineLife expectancybusinessphysical healthmental healthProgramme Grants for Applied Research
researchProduct

Substance use, medication adherence and outcome one year following a first episode of psychosis

2016

Both substance use and poor medication adherence are associated with poor outcome in psychosis. To clarify the contributions of substance use and poor medication adherence to poor outcome in the year following a first episode of psychosis, 205 patients were evaluated for use of tobacco, alcohol, cannabis and stimulants at their psychosis onset, and in a 1-year follow-up. Data on medication adherence and symptom remission were also collected. Patients had high rates of overall substance use before (37-65%) and after psychosis onset (45-66%). 44% showed poor medication adherence and 55% did not reach remission from psychosis. Nicotine dependence and cannabis use after psychosis onset signific…

Nicotine dependenceAdultMalePsychosismedicine.medical_specialtyFirst episode psychosisRemissionSubstance-Related DisordersMedication adherenceSubstance useCannabis useMedication AdherenceCannabis use; First episode psychosis; Medication adherence; Nicotine dependence; Remission; Substance use; Acute Disease03 medical and health sciencesYoung Adult0302 clinical medicineSettore M-PSI/08 - Psicologia ClinicamedicineHumansYoung adultCannabis use; First episode psychosis; Medication adherence; Nicotine dependence; Remission; Substance use; Acute Disease; Adult; Antipsychotic Agents; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Middle Aged; Psychotic Disorders; Substance-Related Disorders; Treatment Outcome; Young AdultNicotine dependencePsychiatryMedication adherenceSettore MED/25 - PsichiatriaBiological PsychiatryFirst episodebiologyCannabis useMiddle Agedmedicine.diseasebiology.organism_classificationFirst episode psychosi030227 psychiatryTreatment OutcomePsychotic DisordersPsychiatry and Mental HealthAcute DiseaseFemaleCannabisSubstance usePsychology030217 neurology & neurosurgeryAntipsychotic AgentsFollow-Up Studies
researchProduct

Structural Covariance of Cortical Gyrification at Illness Onset in Treatment Resistance: A Longitudinal Study of First-Episode Psychoses

2021

AbstractTreatment resistance (TR) in patients with first-episode psychosis (FEP) is a major cause of disability and functional impairment, yet mechanisms underlying this severe disorder are poorly understood. As one view is that TR has neurodevelopmental roots, we investigated whether its emergence relates to disruptions in synchronized cortical maturation quantified using gyrification-based connectomes. Seventy patients with FEP evaluated at their first presentation to psychiatric services were followed up using clinical records for 4 years; of these, 17 (24.3%) met the definition of TR and 53 (75.7%) remained non-TR at 4 years. Structural MRI images were obtained within 5 weeks from first…

AdultAffective Disorders PsychoticMalePsychosisLongitudinal studymedicine.medical_specialtyAdolescentlongitudinalAcademicSubjects/MED00810treatment-resistantYoung Adult03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansLongitudinal Studiesfirst-episode psychosisGyrificationClozapineCerebral CortexFirst episodeclozapinebusiness.industryFunctional data analysisgyrificationmedicine.diseaseMagnetic Resonance Imaging030227 psychiatryschizophreniaPsychiatry and Mental healthPsychotic DisordersSchizophreniaConnectomeCardiologyFemaleNerve Netbusiness030217 neurology & neurosurgeryAntipsychotic AgentsFollow-Up StudiesRegular ArticlesMRImedicine.drugSchizophrenia Bulletin
researchProduct

Tobacco smoking and nicotine dependence in first episode and established psychosis

2019

Aim\ud People with psychotic disorders have increased premature mortality in comparison with the general population, with high rates of cigarette use a contributing factor. We aimed to describe the prevalence of cigarette use and nicotine dependence (ND) in first episode psychosis (FEP), and established psychosis; and to investigate associations between clinical symptoms and ND.\ud \ud Methodology\ud Smoking and clinical data were collected from two cohorts: 181 people with FEP recruited as part of the Physical Health and Substance Use Measures in First Onset Psychosis (PUMP) study and from 432 people with established psychosis recruited as part of the Improving\ud physical health and reduc…

AdultMalePsychosismedicine.medical_specialtyAdolescentmedia_common.quotation_subjectmedicine.medical_treatmentPopulationAddictionPhysical healthComorbiditySubstance useCigarette SmokingNicotineYoung AdultmedicineHumanseducationPsychiatryPsychoticGeneral PsychologyRandomized Controlled Trials as Topicmedia_commonFirst episodeeducation.field_of_studybusiness.industryAddictionSmokingTobacco Use DisorderGeneral Medicinemedicine.diseaseUnited KingdomPsychiatry and Mental healthPsychotic DisordersSchizophreniaCohortSchizophreniaSmoking cessationFemalebusinessmedicine.drug
researchProduct

Vitamin D and clinical symptoms in First Episode Psychosis (FEP): A prospective cohort study

2019

BACKGROUND: There is a paucity of longitudinal research investigating vitamin D in people with early psychosis.METHOD: Vitamin D levels were measured in 168 patients (64% (n = 108) male, mean age 29.3 (9.8) years) with first episode psychosis (FEP), along with measures of clinical state at baseline and at 12 months follow up. We assessed the a) cross sectional, and; b) longitudinal relationships between continuous and categorical 25-hydroxyvitamin D (25(OH)D) levels and clinical symptoms at first contact for psychosis and at 12 months.RESULTS: In FEP, 80% (n = 134) at baseline, and 76% at 12 months follow up, had suboptimal vitamin D levels (<20 ng/ml). Suboptimal levels of 25 (OH) D at …

AdultMalemedicine.medical_specialtyPsychosisCognitiveCross-sectional studyYoung Adult03 medical and health sciences0302 clinical medicineInternal medicineFirst episode psychosismedicineVitamin D and neurologyHumansLongitudinal StudiesProspective Studies25-hydroxyvitamin D (25(OH)D)Vitamin DYoung adultProspective cohort studyBiological PsychiatryNegative symptombusiness.industryFEPPsychosismedicine.disease030227 psychiatryPsychiatry and Mental healthCross-Sectional StudiesPsychotic DisordersSchizophreniaLongitudinalSchizophreniaFemaleNegative symptomsbusiness030217 neurology & neurosurgerySchizophrenia Research
researchProduct

Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries.

2016

BACKGROUND: In people with psychosis, physical comorbidities, including cardiovascular and metabolic diseases, are highly prevalent and leading contributors to the premature mortality encountered. However, little is known about physical health multimorbidity in this population or in people with subclinical psychosis and in low- and middle-income countries (LMICs). This study explores physical health multimorbidity patterns among people with psychosis or subclinical psychosis. METHODS: Overall, data from 242,952 individuals from 48 LMICs, recruited via the World Health Survey, were included in this cross-sectional study. Participants were subdivided into those (1) with a lifetime diagnosis o…

MaleInternationalityCross-sectional studyComorbidityMetabolism Multimorbidity Physical health Psychosis Psychotic experiencesGlobal HealthLogistic regressionnot known0302 clinical medicinePrevalencepsychosisSubclinical infectionPsychosisPhysical healthMultimorbidityPsychotic experiencesMetabolismmetabolismmultimorbidityphysical healthpsychosispsychotic experiencesMedicine(all)Principal Component Analysiseducation.field_of_studyGeneral MedicineMiddle AgedCardiovascular DiseasesFemalemedicine.symptomAdultPsychosismedicine.medical_specialtyAdolescentmultimorbidityVisual impairmentPopulationPhysical healthYoung Adult03 medical and health sciencesMetabolic DiseasesmedicineHumansPsychotic experiencesPsychiatryeducationPovertyAgedbusiness.industryPublic healthMultimorbidityPsychosismedicine.diseaseHealth SurveysComorbidity030227 psychiatryCross-Sectional StudiesMetabolismPsychotic DisordersChronic Diseasebusiness030217 neurology & neurosurgery
researchProduct